The World Vaccine Congress Washington is well-established as the leading event on vaccines each year. Now turning 16, you are guaranteed the best experience on-site ever.
Under this roof, the World Vaccine for Emerging & Re-emerging Diseases Conference will cover the crucial topics which are affecting the whole sector. From finding ways to overcome big challenges to progress, to exploring the technological developments which are changing how cures are researched, manufactured and distributed.
In 2015, a new format was born which allows for these whole-sector topics, and also gives an opportunity for people to find out more about their specific area of research and their job-function. By running parallel niche conferences over part of the Congress, it increased the relevance of the whole event for everyone who attends.
The impact of this was to increase the quality of the speaker line-up and those who signed up to attend, as the content truly moved forward, covering the important blue-sky keynotes whilst also providing personalised content for every attendee.
One of our sponsors commented that 2015 was the best attendee list they had seen so far, and they and been involved in World Vaccine Congress for several years.
In 2016, we will be building on this success to bring the community together for debate and discussion that is not available elsewhere, because of the quality of sessions you can participate in and the attendees who will be on-site.
Make sure you don’t miss out on the one event which facilitates the future of the vaccine industry.
Make sure you are at the forefront of the vaccines industry. No matter where your interest lies, we have content, networking and potential partners for you.
By bringing seven events together under one roof, you get to choose the sessions which are the most applicable to help your business plan for the future of vaccine research, development and manufacture.
Take just three days out of the office to meet with 600+ potential customers who need to find solutions to their challenges.
INFLUENZA AND RESPIRATORY
Find ways to improve development of universal influenza, RSV, MERS and Pneumococcal vaccines
BIOPROCESSING AND MANUFACTURING
Optimize early formulation through to clinical manufacturing, by embracing new techniques and technologies
CANCER AND IMMUNOTHERAPY
From new adjuvant technologies to novel immunotherapies, better understand the latest developments in the fast-evolving cancer landscape
Hear from exciting new vaccine biotechs presenting on their pipeline as well as case studies and on how best to form public-private partnerships
EMERGING AND RE-EMERGING DISEASES
Understand the opportunities for your business in reacting to global threats like malaria, dengue and Ebola
Assess how to improve your clinical trial performance, from developing novel immunological assays to creating clinical efficacy
From livestock to companion, gain crucial insights into the emerging infections and new technologies changing the landscape